Btg Share Discussion Threads

[bargainbob] 09/9/2018 21:42

Hopefully 5 is actually happening after rumour . Only expect 15 per cent though from here. With the low pound , if no one strikes before year end then suspect no one will for a considerable time.

[a1ord53] 07/9/2018 17:17

SP - Its been manipulated by algo trading by investment bankers , cause BTG may do bigger deal than today next week paying with stock.
I remember how BTG share price in 2008 went from 90p to 240p in 2 months and they bought Protherics in all shares deal for 65p and BTG shares after deal went down to 113 p .
Some thoughts what we can expect :
1 Varithena - good results or bad results - not before next update october- november - until now only weak numbers - I called 3 doctors from Varithena.com and nobody was happy with demand of Varithena and I tried to find how many doctors offer Varithena but found only 7 doctors in east usa and in west btg site didnt work properly or they just dont have anymore doctors in Florida and California. Try to go to varithena.com and it will bring you to btg site where is link ‚‘ find doctor near you „“
2 Btg buys competition ( Anavip ? ) or makes merger or makes competitive pricing for snake vaccine.
3 No new products in research and developement
4 May sell bead business( not profitable until now) to Chinese
5 Get bid for whole BTG - what premium buyers are going to offer ?
6 New product ( last purchase announced on Friday) first results end of next year.
Bottom line - no double digit growth to expect like promised by Louise .What share price to expect ?

Only strong recommendation is from Numis with target price 840 p, but Numis had strong buy recommendation for Vectura with target price 240 p and now Vectura is 74 p . All other recommendations is hold.
All trading last 2 weeks were algorythme programms using up buy momentum - for how long ? Or will they do reverse algo to sell programm ?
I sold most of my holdings in 6-6.9 £ range and will try tomorrow to sell above 5.7 £ 70% of my remaining holding . We may see testing last month lows around 5 € imo . May be not ?
Any thoughts ? Or advise ?

[spyder] 07/9/2018 17:09

Lovely chart :-)

[spyder] 07/9/2018 17:08

US investors did like the deal more than the UK did - yeay!

[a1ord53] 07/9/2018 16:49

CT where is your share price 3-4 £ projection ?

[bargainbob] 07/9/2018 16:44

Next weeks news will be even better cannot wait.

[fhmktg] 07/9/2018 16:28

I think this will support the EKOS business, but if V does show some promise,this we would form a very significant group for both BTG or for sale.

[spyder] 07/9/2018 11:15

Goods points GM.

[gregmorg] 07/9/2018 10:20

Mm, it strikes me that this acquisition sends a much better signal to investors than has been appreciated. It appears to strengthen/widens the vein offering from Varithena. Fears that the Varithena treatment maybe discontinued as sales were not building so that big write downs are inevitable or expected this year now looks less of a threat. It strikes me that Varithena is a bit more of a cornerstone. We shall see!.

[spyder] 07/9/2018 09:05

US investors might like the deal more than the UK response so far ...

[spyder] 07/9/2018 09:05

This is a brilliant strategic acquisition that complements the existing portfolio. If the product is good enough, it should virtually sell itself.
I am confident that the mistakes with Vistogard will not be repeated. The Chairman reassured investors at the AGM that a thorough forensic PM of the case was conducted at the time and lessons will have been learned. If not ... ? Well, 2 strikes and you are out!
Just check out these comments about Sentry from one of the investigators:

HOLLYWOOD, FL—For patients at risk of pulmonary embolism (PE), a new type of inferior vena cava (IVC) filter may resolve issues inherent to earlier models by neither remaining in place nor needing to be retrieved.

The device “represents an important paradigm shift in the prevention of PE,” said investigator Michael Dake, MD (Stanford University, CA), presenting 1-year findings from the SENTRY study at the recent International Symposium on Endovascular Therapy 2018.

“I think it’s fair to characterize the field of IVC filters over the last decade as rife with controversy,” Dake commented. With the advent of retrievable filters, use rose between 2005 and 2010. But use then fell following the 2010 US Food and Drug Administration’;s alert over complications associated with the devices.

“What’s not controversial is pulmonary embolism,” he stressed, noting that one in 10 hospital deaths are PE-related. “Used correctly, IVC filters save lives and reduce injury and costs related to PE.” However, existing technologies are not meeting the needs of patients or clinicians, Dake said.

Made of a stable frame plus filter arms held together by a bioabsorbable filament, Sentry (Novate Medical) is meant to provide patients with protection against PE during transient periods of high risk. After about 60 days, hydrolysis of the filament enables the arms to retract against the IVC, with the “bioconvertible” device leaving behind a patent lumen.

This not only reduces the risk of IVC occlusion and other complications, Dake stressed, but also removes the need for retrieval and its associated risk and cos

[fhmktg] 07/9/2018 08:33

The market seems to be assuming she can!

[bargainbob] 07/9/2018 07:48

Good point Alord , maybe this opens more doors. Though from experience only more pressure to put on the sales force and focus is lost.

Louise cannot make the same mistake twice can she.

[a1ord53] 07/9/2018 07:45

BTG plans to launch Sentry in the US in the second half of FY2018/19 and will sell the device through its existing vascular sales force.
The same sales force , which distributing Varithena with no success ?
Assets this company had on 31 of December 2017 were aprox 3 million with debt 2 million - purchase price 20 mil plus may be 130 mil - hope they know what they doing and not because desparate to replace wrote down other purchases ???

[bargainbob] 07/9/2018 07:42

That the news I was waiting for . Action at last .Hope Louise has the sales force to deliver or another 100 million lawsuit in 2 years.

[bargainbob] 06/9/2018 21:09

Oh lovely flow on this today.

[bargainbob] 05/9/2018 17:29

Not today Greg , is a dollar value baby.

[gregsc] 05/9/2018 12:49

er Is something happening?
It's done this before only to fall back later.

[cannyshoveyergrannyoffthebus] 05/9/2018 12:38

555 alive wow

[a1ord53] 05/9/2018 10:26

Where is CT with 3-4 £ projection ?
Varithena ? Dont believe , physicians not using it in USA according press

[gregsc] 05/9/2018 10:19

Let's hope it holds this time.

[fhmktg] 05/9/2018 09:46

Looking exciting!

[bargainbob] 05/9/2018 07:41

Morning all , are we awaiting a good news day ?

[bargainbob] 04/9/2018 17:21

Then it went to sleep at 5:40